Navigation Links
New Oral Anticoagulants Markets
Date:3/25/2013

11.9 Eli Lilly & Co 222
11.9.1 Effient (Daiichi Sankyo) 222
11.9.2 General Risk of Bleeding 223
11.9.3 Coronary Artery By-Pass Graft Surgery-Related Bleeding 224
11.9.4 Discontinuation of Effient 224
11.9.5 Thrombotic Thrombocytopenic Purpura 224
11.9.6 Hypersensitivity Including Angiodema 225
11.9.7 Clinical Studies 225
11.10 Genentech, Inc. 227
11.10.1 Activase (Altepase) 227
11.11 GlaxoSmithKline PLC 227
11.11.1 Fondaparinux 228
11.12 Medicure, Inc. 228
11.12.1 Aggrastat 228
11.13 Merck & Co., Inc. 229
11.13.1 SCH 5303348 229
11.14 Novartis AG 229
11.14.1 Elinogrel 229
11.15 Ortho-McNeil Pharmaceutical, Inc. 229
11.15.1 Rivaroxaban (Xarelto) 230
11.16 Pfizer, Inc. 230
11.16.1 Eliquis (Apixaban) 230
11.17 Pharmion, LLC 230
11.17.1 Tinzaparin (Innohep) 231
11.18 Portola Pharmaceuticals, Inc. 231
11.19 Sanofi 232
11.19.1 Lovenox (Enoxaparin) 232
11.19.2 Idrabiotaparinux 233
11.20 The Medicines Company 233
11.20.1 Argatroban 233
11.20.2 Angiomax (Bivalirudin) 234

Appendix 1: Innovations in Cardiac Rhythm Management with New Anticoagulants 235
Appendix 1.1: Dual Antiplatelet Therapy 236
Appendix 1.2: Direct Thrombin Inhibitors 236
Appendix 1.3: Factor Xa Inhibitors 238
Appendix 1.4: Comparing the Trials 240
Appendix 1.5: Interventions Targeting the Left Atrial Appendage 241
Appendix 2: Oral Contraceptives and the Risk of Venous Thromboembolism 244
Appendix 2.1: Hormonal Effects on Venus Thromboembolism 244
Appendix 2.2: Assessing Venous Thromboembolism Risks of Oral Contraceptives 245
Appendix 2.3: Recent Research 245

INDEX OF FIGURES

Figure 2.1: Almost 100 Years of Anticoagulation Therapy 17
Figure 2.2: Site of Action of New Anticoagulants 22
Figure 3.1: Pathway of Dabigatran Action 36
Figure 3.2: Sites of Action of Dabigatran and Rivaroxaban 45
Figure 3.3: Time to Firs
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Global Anticoagulants Industry
2. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
3. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
4. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
5. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
6. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
7. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
8. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
9. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
10. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
11. Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  AbbVie (NYSE: ... Phase 3 GIFT-I study of its investigational, all-oral, ... treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of ... Japan . 1 GIFT-I evaluated ... infected Japanese patients, with and without cirrhosis, who ...
(Date:5/26/2015)... -- Thoratec Corporation (NASDAQ: THOR ), a world ... and restore failing hearts, said today it will participate ... Conference on Tuesday, June 9. D. ... provide an update on the company, beginning at 2:00 ... The presentation will be available through the ...
(Date:5/26/2015)... , May 26, 2015  Amgen (NASDAQ: AMGN ... the Phase 3 OPTiM study in the Journal ... The data published in JCO , which were ... Society of Clinical Oncology (ASCO) in 2013 and 2014, ... patients with unresected stage IIIB, IIIC or IV metastatic ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6Thoratec Presentation At Goldman Sachs Healthcare Conference To Be Webcast 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8
(Date:5/26/2015)... 2015 Now offering innovative, safe, and ... of Dr. Hedi Belajouza in Tunisia extends ... Perfection to the last detail — meticulous hair placement, ... of the harvested follicle — are all results in ... visible in the artistry and talent of Tunisian hair ...
(Date:5/26/2015)... 26, 2015 The American Association of ... 55 poison centers applaud the efforts of the United ... according to Stephen T. Kaminski, JD, AAPCC CEO and ... Substances Act, introduced by Senator Edward J. Markey on ... opioid pain medications and other controlled substances to undergo ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Sexual harassment and ... Title IX is best known for creating opportunities in women's ... for sexual assault response and prevention. In a recent episode ... Global Sports Advocates explains what Title IX means for ... get in front of this issue to protect students. , ...
(Date:5/26/2015)... 2015 Marching bands across the ... and thanks to the efforts of Etymotic Research, ... their musicians are protecting their hearing with Etymotic’s ... participating groups, Etymotic’s Adopt-a-Band program continues to add ... now for sale in drum shops and musical ...
(Date:5/26/2015)... 26, 2015 Irwin Gross, M.D., ... a hospital-wide Patient Blood Management (PBM) initiative at Eastern ... blood usage by more than 60 percent and improved ... in detail in an article in the May 2015 ... reduced perioperative red cell loss, less acute kidney injury ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 2Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 3Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 4Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 2Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 3Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:Marching Musicians Getting In Step With Hearing Protection 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3
... development of a healthy "designer fat" that, when added to ... in high quantities, but isn,t available in large enough amounts ... oil, also could boost nutrition for babies who are bottle-fed ... of Agricultural and Food Chemistry . Casimir Akoh and ...
... comprehensive analyses to date of the cost of robotic-assisted, laparoscopic ... now-dominant surgical approach is significantly more costly than standard open ... The results of the study are available online and will ... . In one of the first studies based ...
... WASHINGTON - The second edition of Law and the American ... 15, 2012. Building on its 1997 predecessor, the second edition ... of law and the U.S. health care system. Law and ... unprecedented change in how health care is organized, financed, and ...
... new study at Karlstad University in Sweden shows that phthalates ... Phthalates are substances suspected to cause asthma and allergies, as ... that children can ingest these softening agents with food but ... a group of chemical compounds that occur in construction materials ...
... HealthDay Reporter , TUESDAY, May 22 (HealthDay News) ... procedure, which involves threading a camera through the colon ... new study has found that patients overwhelmingly preferred colonoscopy ... scan. Colonoscopy has long been the standard ...
... Prior treatment with inhaled corticosteroids in patients with ... associated with a lower incidence and severity of parapneumonic ... Spain. , A parapneumonic effusion is a type of ... pleural layers, the fluid-filled space that surrounds the lungs) ...
Cached Medicine News:Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Landmark textbook on health care and the US legal system released 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2
The cementless biomEx cup can be used with both cemented and cementless femoral stems....
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
For primary and revision cases...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Medicine Products: